 | • レポートコード：D0GIR-08825 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ベタヒスチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ベタヒスチンの種類別市場規模（8mg、25mg、その他）、用途別市場規模（脳血栓症、脳塞栓症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：TOWA PHARMACEUTICAL CO., LTD、Ciclum Farma Unipessoal、EA Pharma Co., Ltd.、Nichi-Iko Pharmaceutical、DOC Generici、Takeda Pharmaceutical Company Limited、Orion Corporation、HENNIG ARZNEIMITTEL GmbH & Co. KG、Disphar International B.V.、Mylan ・地域別グローバル市場分析 2015年-2020年 ・ベタヒスチンの北米市場（アメリカ、カナダ、メキシコ） ・ベタヒスチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ベタヒスチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ベタヒスチンの南米市場（ブラジル、アルゼンチン） ・ベタヒスチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：8mg、25mg、その他 ・用途別分析：脳血栓症、脳塞栓症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Betahistine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Betahistine sales will be xx in 2020 from Betahistine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Betahistine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Betahistine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Betahistine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Betahistine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Betahistine market has been segmented into
8mg
25mg
Others
By Application, Betahistine has been segmented into:
Cerebral Thrombosis
Cerebral Embolism
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Betahistine market presented in the report. This section sheds light on the sales growth of different regional and country-level Betahistine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Betahistine market.
The report offers in-depth assessment of the growth and other aspects of the Betahistine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Betahistine Market Share Analysis
Betahistine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Betahistine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Betahistine sales, revenue and market share for each player covered in this report.
The major players covered in Betahistine are:
TOWA PHARMACEUTICAL CO., LTD
Ciclum Farma Unipessoal
EA Pharma Co., Ltd.
Nichi-Iko Pharmaceutical
DOC Generici
Takeda Pharmaceutical Company Limited
Orion Corporation
HENNIG ARZNEIMITTEL GmbH & Co. KG
Disphar International B.V.
Mylan
Among other players domestic and global, Betahistine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Betahistine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Betahistine, with price, sales, revenue and global market share of Betahistine in 2018 and 2019.
Chapter 3, the Betahistine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Betahistine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Betahistine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Betahistine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Betahistine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Betahistine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 8mg
1.2.3 25mg
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Betahistine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cerebral Thrombosis
1.3.3 Cerebral Embolism
1.3.4 Others
1.4 Overview of Global Betahistine Market
1.4.1 Global Betahistine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Betahistine Industry Impact
1.6.1 COVID-19 Potential Implications for the Betahistine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Betahistine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 TOWA PHARMACEUTICAL CO., LTD
2.1.1 TOWA PHARMACEUTICAL CO., LTD Details
2.1.2 TOWA PHARMACEUTICAL CO., LTD Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 TOWA PHARMACEUTICAL CO., LTD SWOT Analysis
2.1.4 TOWA PHARMACEUTICAL CO., LTD Product and Services
2.1.5 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ciclum Farma Unipessoal
2.2.1 Ciclum Farma Unipessoal Details
2.2.2 Ciclum Farma Unipessoal Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ciclum Farma Unipessoal SWOT Analysis
2.2.4 Ciclum Farma Unipessoal Product and Services
2.2.5 Ciclum Farma Unipessoal Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 EA Pharma Co., Ltd.
2.3.1 EA Pharma Co., Ltd. Details
2.3.2 EA Pharma Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 EA Pharma Co., Ltd. SWOT Analysis
2.3.4 EA Pharma Co., Ltd. Product and Services
2.3.5 EA Pharma Co., Ltd. Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Nichi-Iko Pharmaceutical
2.4.1 Nichi-Iko Pharmaceutical Details
2.4.2 Nichi-Iko Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Nichi-Iko Pharmaceutical SWOT Analysis
2.4.4 Nichi-Iko Pharmaceutical Product and Services
2.4.5 Nichi-Iko Pharmaceutical Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 DOC Generici
2.5.1 DOC Generici Details
2.5.2 DOC Generici Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DOC Generici SWOT Analysis
2.5.4 DOC Generici Product and Services
2.5.5 DOC Generici Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda Pharmaceutical Company Limited
2.6.1 Takeda Pharmaceutical Company Limited Details
2.6.2 Takeda Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda Pharmaceutical Company Limited SWOT Analysis
2.6.4 Takeda Pharmaceutical Company Limited Product and Services
2.6.5 Takeda Pharmaceutical Company Limited Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Orion Corporation
2.7.1 Orion Corporation Details
2.7.2 Orion Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Orion Corporation SWOT Analysis
2.7.4 Orion Corporation Product and Services
2.7.5 Orion Corporation Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 HENNIG ARZNEIMITTEL GmbH & Co. KG
2.8.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Details
2.8.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 HENNIG ARZNEIMITTEL GmbH & Co. KG SWOT Analysis
2.8.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Product and Services
2.8.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Disphar International B.V.
2.9.1 Disphar International B.V. Details
2.9.2 Disphar International B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Disphar International B.V. SWOT Analysis
2.9.4 Disphar International B.V. Product and Services
2.9.5 Disphar International B.V. Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mylan SWOT Analysis
2.10.4 Mylan Product and Services
2.10.5 Mylan Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Betahistine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Betahistine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Betahistine Manufacturer Market Share in 2019
3.3.2 Top 6 Betahistine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Betahistine Sales, Revenue and Market Share by Regions
4.1.1 Global Betahistine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Betahistine Revenue and Market Share by Regions (2015-2020)
4.2 North America Betahistine Sales and Growth Rate (2015-2020)
4.3 Europe Betahistine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Betahistine Sales and Growth Rate (2015-2020)
4.5 South America Betahistine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Betahistine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Betahistine Sales, Revenue and Market Share by Country
5.1.1 North America Betahistine Sales and Market Share by Country (2015-2020)
5.1.2 North America Betahistine Revenue and Market Share by Country (2015-2020)
5.2 United States Betahistine Sales and Growth Rate (2015-2020)
5.3 Canada Betahistine Sales and Growth Rate (2015-2020)
5.4 Mexico Betahistine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Betahistine Sales, Revenue and Market Share by Country
6.1.1 Europe Betahistine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Betahistine Revenue and Market Share by Country (2015-2020)
6.2 Germany Betahistine Sales and Growth Rate (2015-2020)
6.3 UK Betahistine Sales and Growth Rate (2015-2020)
6.4 France Betahistine Sales and Growth Rate (2015-2020)
6.5 Russia Betahistine Sales and Growth Rate (2015-2020)
6.6 Italy Betahistine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Betahistine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Betahistine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Betahistine Revenue and Market Share by Regions (2015-2020)
7.2 China Betahistine Sales and Growth Rate (2015-2020)
7.3 Japan Betahistine Sales and Growth Rate (2015-2020)
7.4 Korea Betahistine Sales and Growth Rate (2015-2020)
7.5 India Betahistine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Betahistine Sales and Growth Rate (2015-2020)
7.7 Australia Betahistine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Betahistine Sales, Revenue and Market Share by Country
8.1.1 South America Betahistine Sales and Market Share by Country (2015-2020)
8.1.2 South America Betahistine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Betahistine Sales and Growth Rate (2015-2020)
8.3 Argentina Betahistine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Betahistine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Betahistine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Betahistine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Betahistine Sales and Growth Rate (2015-2020)
9.3 Turkey Betahistine Sales and Growth Rate (2015-2020)
9.4 Egypt Betahistine Sales and Growth Rate (2015-2020)
9.5 South Africa Betahistine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Betahistine Sales and Market Share by Type (2015-2020)
10.2 Global Betahistine Revenue and Market Share by Type (2015-2020)
10.3 Global Betahistine Price by Type (2015-2020)
11 Global Betahistine Market Segment by Application
11.1 Global Betahistine Sales Market Share by Application (2015-2020)
11.2 Global Betahistine Revenue Market Share by Application (2015-2020)
11.3 Global Betahistine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Betahistine Sales, Revenue and Growth Rate (2021-2025)
12.2 Betahistine Market Forecast by Regions (2021-2025)
12.2.1 North America Betahistine Market Forecast (2021-2025)
12.2.2 Europe Betahistine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Betahistine Market Forecast (2021-2025)
12.2.4 South America Betahistine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Betahistine Market Forecast (2021-2025)
12.3 Betahistine Market Forecast by Type (2021-2025)
12.3.1 Global Betahistine Sales Forecast by Type (2021-2025)
12.3.2 Global Betahistine Market Share Forecast by Type (2021-2025)
12.4 Betahistine Market Forecast by Application (2021-2025)
12.4.1 Global Betahistine Sales Forecast by Application (2021-2025)
12.4.2 Global Betahistine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Betahistine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Betahistine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Betahistine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Betahistine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. TOWA PHARMACEUTICAL CO., LTD Basic Information, Manufacturing Base and Competitors
Table 9. TOWA PHARMACEUTICAL CO., LTD Betahistine Major Business
Table 10. TOWA PHARMACEUTICAL CO., LTD Betahistine Total Revenue (USD Million) (2018-2019)
Table 11. TOWA PHARMACEUTICAL CO., LTD SWOT Analysis
Table 12. TOWA PHARMACEUTICAL CO., LTD Betahistine Product and Services
Table 13. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Ciclum Farma Unipessoal Basic Information, Manufacturing Base and Competitors
Table 15. Ciclum Farma Unipessoal Betahistine Major Business
Table 16. Ciclum Farma Unipessoal Betahistine Total Revenue (USD Million) (2018-2019)
Table 17. Ciclum Farma Unipessoal SWOT Analysis
Table 18. Ciclum Farma Unipessoal Betahistine Product and Services
Table 19. Ciclum Farma Unipessoal Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. EA Pharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 21. EA Pharma Co., Ltd. Betahistine Major Business
Table 22. EA Pharma Co., Ltd. Betahistine Total Revenue (USD Million) (2018-2019)
Table 23. EA Pharma Co., Ltd. SWOT Analysis
Table 24. EA Pharma Co., Ltd. Betahistine Product and Services
Table 25. EA Pharma Co., Ltd. Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 27. Nichi-Iko Pharmaceutical Betahistine Major Business
Table 28. Nichi-Iko Pharmaceutical Betahistine Total Revenue (USD Million) (2018-2019)
Table 29. Nichi-Iko Pharmaceutical SWOT Analysis
Table 30. Nichi-Iko Pharmaceutical Betahistine Product and Services
Table 31. Nichi-Iko Pharmaceutical Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. DOC Generici Basic Information, Manufacturing Base and Competitors
Table 33. DOC Generici Betahistine Major Business
Table 34. DOC Generici Betahistine Total Revenue (USD Million) (2018-2019)
Table 35. DOC Generici SWOT Analysis
Table 36. DOC Generici Betahistine Product and Services
Table 37. DOC Generici Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Limited Betahistine Major Business
Table 40. Takeda Pharmaceutical Company Limited Betahistine Total Revenue (USD Million) (2018-2019)
Table 41. Takeda Pharmaceutical Company Limited SWOT Analysis
Table 42. Takeda Pharmaceutical Company Limited Betahistine Product and Services
Table 43. Takeda Pharmaceutical Company Limited Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 45. Orion Corporation Betahistine Major Business
Table 46. Orion Corporation Betahistine Total Revenue (USD Million) (2018-2019)
Table 47. Orion Corporation SWOT Analysis
Table 48. Orion Corporation Betahistine Product and Services
Table 49. Orion Corporation Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table 51. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Major Business
Table 52. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Total Revenue (USD Million) (2018-2019)
Table 53. HENNIG ARZNEIMITTEL GmbH & Co. KG SWOT Analysis
Table 54. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product and Services
Table 55. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Disphar International B.V. Basic Information, Manufacturing Base and Competitors
Table 57. Disphar International B.V. Betahistine Major Business
Table 58. Disphar International B.V. Betahistine Total Revenue (USD Million) (2018-2019)
Table 59. Disphar International B.V. SWOT Analysis
Table 60. Disphar International B.V. Betahistine Product and Services
Table 61. Disphar International B.V. Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Mylan Basic Information, Manufacturing Base and Competitors
Table 63. Mylan Betahistine Major Business
Table 64. Mylan Betahistine Total Revenue (USD Million) (2018-2019)
Table 65. Mylan SWOT Analysis
Table 66. Mylan Betahistine Product and Services
Table 67. Mylan Betahistine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Betahistine Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global Betahistine Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Betahistine Sales by Regions (2015-2020) (K Units)
Table 71. Global Betahistine Sales Market Share by Regions (2015-2020)
Table 72. Global Betahistine Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Betahistine Sales by Countries (2015-2020) (K Units)
Table 74. North America Betahistine Sales Market Share by Countries (2015-2020)
Table 75. North America Betahistine Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Betahistine Revenue Market Share by Countries (2015-2020)
Table 77. Europe Betahistine Sales by Countries (2015-2020) (K Units)
Table 78. Europe Betahistine Sales Market Share by Countries (2015-2020)
Table 79. Europe Betahistine Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Betahistine Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific Betahistine Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Betahistine Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Betahistine Sales by Countries (2015-2020) (K Units)
Table 84. South America Betahistine Sales Market Share by Countries (2015-2020)
Table 85. South America Betahistine Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Betahistine Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Betahistine Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa Betahistine Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Betahistine Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Betahistine Revenue Market Share by Countries (2015-2020)
Table 91. Global Betahistine Sales by Type (2015-2020) (K Units)
Table 92. Global Betahistine Sales Share by Type (2015-2020)
Table 93. Global Betahistine Revenue by Type (2015-2020) (USD Million)
Table 94. Global Betahistine Revenue Share by Type (2015-2020)
Table 95. Global Betahistine Sales by Application (2015-2020) (K Units)
Table 96. Global Betahistine Sales Share by Application (2015-2020)
Table 97. Global Betahistine Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global Betahistine Market Share Forecast by Regions (2021-2025)
Table 99. Global Betahistine Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global Betahistine Market Share Forecast by Type (2021-2025)
Table 101. Global Betahistine Sales Forecast by Application (2021-2025)
Table 102. Global Betahistine Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Betahistine Picture
Figure 2. Global Sales Market Share of Betahistine by Type in 2019
Figure 3. 8mg Picture
Figure 4. 25mg Picture
Figure 5. Others Picture
Figure 6. Betahistine Sales Market Share by Application in 2018
Figure 7. Cerebral Thrombosis Picture
Figure 8. Cerebral Embolism Picture
Figure 9. Others Picture
Figure 10. Global Betahistine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Betahistine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Betahistine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Betahistine Sales Market Share by Manufacturer in 2019
Figure 31. Global Betahistine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Betahistine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Betahistine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Betahistine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Betahistine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Betahistine Revenue Market Share by Regions in 2018
Figure 39. North America Betahistine Sales and Growth Rate (2015-2020)
Figure 40. Europe Betahistine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Betahistine Sales and Growth Rate (2015-2020)
Figure 42. South America Betahistine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Betahistine Sales and Growth Rate (2015-2020)
Figure 44. North America Betahistine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Betahistine Sales Market Share by Countries (2015-2020)
Figure 46. North America Betahistine Sales Market Share by Countries in 2018
Figure 47. North America Betahistine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Betahistine Revenue Market Share by Countries in 2018
Figure 49. United States Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Betahistine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Betahistine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Betahistine Revenue Market Share by Countries in 2019
Figure 55. Germany Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Betahistine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Betahistine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Betahistine Revenue Market Share by Regions 2019
Figure 63. China Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Betahistine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Betahistine Sales Market Share by Countries in 2019
Figure 70. South America Betahistine Revenue Market Share by Countries in 2019
Figure 71. Brazil Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Betahistine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Betahistine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Betahistine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Betahistine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Betahistine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Betahistine Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Betahistine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Betahistine Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Betahistine Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Betahistine Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Betahistine Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Betahistine Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
TAVI用脳塞栓保護装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cerebral Embolic Protection Devices for TAVI market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- 脳血栓除去システムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cerebral Thrombectomy Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cerebral Thromb…
- 脳血管ステントの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cerebral Vascular Stent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cerebral Vascular Ste…
- 脳脊髄液（CSF）管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cerebral Spinal Fluid (CSF) Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 893.5 million by 2025, from USD 807.9 million in 2019. The…
- 脳葉酸欠乏症の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cerebral Folate Deficiency market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…